Sort
48,018 grants matching “immunotherapy”
Patient Oriented Research in Viral Malignancies and HIV-associated Cancers
$1,114,919Thomas Uldrick · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA
CIRCULAR MRNA VACCINE PLATFORM FOR IMMUNOTHERAPY OF BREAST CANCER DORMANCY
$1,114,650Virginia Commonwealth University · · FY2022 · Defense Health Agency
CD40L BLOCKADE IN PEDIATRIC RENAL TRANSPLANTATION
$1,114,531Children'S Hospital Boston · U01 · FY2001 · AI
Center for Interventional Oncology
$1,114,489Bradford J Wood · Division Of Basic Sciences - Nci · ZID · FY2019 · CA
Point-of-Care Microfluidics in Lung Cancer
$1,114,356Mehmet Toner · Massachusetts General Hospital · R01 · FY2009 · EB
Clinical Trials of Immunotherapies for Childhood Cancer
$1,113,902Crystal Mackall · Division Of Basic Sciences - Nci · ZIA · FY2014 · CA
Immune Function and the Progression to Type 1 Diabetes
$1,113,383Mark A Atkinson · University Of Florida · P01 · FY2013 · AI
The Boston Lung Cancer Survival Cohort
$1,113,227David C Christiani · Harvard University D/B/A Harvard School Of Public Health · U01 · FY2024 · CA
Regulation of epithelial cell fate decisions in tissue homeostasis and cancer
$1,113,209Ramiro Iglesias-Bartolome · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
Tumor Immune Contexture and Breast Cancer Disparities: A Multi-Disciplinary Study in Women of African and European Ancestry
$1,112,696Christine B. Ambrosone · Roswell Park Cancer Institute Corp · R01 · FY2023 · CA
Engineering HCC-selective PET agent
$1,112,627Freddy Escorcia · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA
CIRCULAR MRNA VACCINE PLATFORM FOR IMMUNOTHERAPY OF BREAST CANCER DORMANCY
$1,112,535Regents Of The University Of Michigan · · FY2022 · Defense Health Agency
New Jersey Pediatric AIDS Clinical Trials Consortium
$1,112,197Univ Of Med/Dent Of Nj-Nj Medical School · U01 · FY2003 · AI
Determine the molecular and metabolic mechanisms by which A-FABP links dysregulated lipid metabolism-induced obesity/breast cancer risk
$1,112,100Bing Li · University Of Iowa · U01 · FY2024 · CA
Immuno/Immuno-Gene Therapies for Thoracic Malignancies
$1,111,842Steven Mark Albelda · University Of Pennsylvania · P01 · FY2013 · CA
Immunology And Pathology Of Acute and Chronic Murine Leukemia Virus Infections
$1,110,653Kim Hasenkrug · National Institute Of Allergy And Infectious Diseases · ZIA · FY2020 · AI
Generation of T-cell receptors recognizing antigens on non-melanoma tumors
$1,110,635James C Yang · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA
Combinational Immunotherapies to Amplify Vaccine Induced Immunity
$1,110,621Elizabeth Marion Jaffee · Johns Hopkins University · U19 · FY2008 · CA
New Jersey Pediatric AIDS Clinical Trials Consortium
$1,110,470Univ Of Med/Dent Of Nj-Nj Medical School · U01 · FY2002 · AI
A Therapeutic DNA Epitope Vaccine for Alzheimer's Disease
$1,109,875Claire Frances Evans · Ichor Medical Systems, Inc. · U44 · FY2011 · NS
iPS cell based immunotherapy for malignant gliomas
$1,109,790John Park · National Institute Of Neurological Disorders And Stroke · ZIA · FY2011 · NS
Mechanisms Of Immune Mediated Restriction Of HIV Replication In LTNP
$1,109,557Mark Connors · National Institute Of Allergy And Infectious Diseases · ZIA · FY2017 · AI
Mechanisms of Effective Humoral Immune Responses to HIV-1
$1,109,557Mark Connors · National Institute Of Allergy And Infectious Diseases · ZIA · FY2017 · AI
Basis for Success of Multidrug-Resistant Enterobacteriaceae
$1,109,278Frank Deleo · National Institute Of Allergy And Infectious Diseases · ZIA · FY2018 · AI
[18F]4FN PET Imaging of Innate Immunity Activation During Immunotherapy-Induced Adverse Events
$1,109,154David R Piwnica-Worms · University Of Tx Md Anderson Can Ctr · R01 · FY2025 · CA